STOCK TITAN

RTW Funds, Roderick Wong report 5.2% stake in Erasca (ERAS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Erasca, Inc. Schedule 13G: RTW Investments, LP and Roderick Wong report shared beneficial ownership of 16,157,175 shares of Erasca common stock, representing 5.2% of the class based on 310,799,547 shares outstanding as of March 5, 2026. The filing shows shared voting and dispositive power over these shares held by the RTW Funds. The statement is signed by Dr. Wong on May 15, 2026.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake reported: RTW Funds and Dr. Wong hold 16.16M shares (5.2%).

The filing lists 16,157,175 shares as beneficially owned with shared voting and dispositive power, calculated from 310,799,547 shares outstanding as of March 5, 2026. This reflects a disclosed, non-control institutional stake held through the RTW Funds.

Cash‑flow treatment and plans for disposition are not stated in the excerpt; subsequent filings would disclose any sales or changes in ownership.

Shares beneficially owned 16,157,175 shares Reported by RTW Investments / Roderick Wong
Percent of class 5.2% Calculated using shares outstanding as of <date>March 5, 2026</date>
Shares outstanding 310,799,547 shares As of <date>March 5, 2026</date> per Form 10-K
beneficially owned regulatory
"The information required by Item 4(a) is set forth in Rows 5 - 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power corporate governance
"Shared Voting Power 16,157,175.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Schedule 13G regulatory
"This statement is filed by: RTW Investments, LP"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.





29479A108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Partner
Date:05/15/2026
Roderick Wong
Signature:s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:05/15/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement

FAQ

What stake does RTW Investments report in Erasca (ERAS)?

RTW Investments reports beneficial ownership of 16,157,175 shares, equal to 5.2% of Erasca common stock based on 310,799,547 shares outstanding as of March 5, 2026.

Does Roderick Wong personally control the ERAS shares reported?

The statement shows Dr. Wong has shared voting and dispositive power over 16,157,175 shares through RTW; it does not assert sole voting or sole dispositive power.

When was the ownership percentage for ERAS calculated?

The 5.2% figure is calculated using 310,799,547 shares outstanding as of March 5, 2026, as reported in the company’s Annual Report on Form 10-K filed March 12, 2026.

Who filed the Schedule 13G for ERAS and when was it signed?

The Schedule 13G was filed by RTW Investments, LP and Roderick Wong, M.D. and is signed by Dr. Wong with a signature date of May 15, 2026.

Are the RTW-held ERAS shares held directly by RTW or on behalf of funds?

The filing states the shares are directly held by the RTW Funds, for which RTW Investments acts as investment adviser and which have the right to receive dividends or sale proceeds.